OTCMKTS:AMFPF Amplifon (AMFPF) Stock Price, News & Analysis $11.21 0.00 (0.00%) As of 06/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestBuy This Stock About Amplifon Stock (OTCMKTS:AMFPF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Amplifon alerts:Sign Up Key Stats Today's Range$11.21▼$11.2150-Day Range$10.09▼$12.6152-Week Range$9.46▼$22.43VolumeN/AAverage Volume6 shsMarket Capitalization$2.47 billionP/E Ratio31.14Dividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare. Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization. The company was listed on the Borsa Italiana in 2001 and has since expanded its footprint through targeted acquisitions and organic growth. Over the decades, Amplifon has integrated complementary businesses and technologies, reinforcing its position in an increasingly competitive global hearing-care market. Today, Amplifon operates thousands of points of sale across more than 20 countries spanning Europe, North America, Latin America and the Asia-Pacific region. Headquartered in Milan, the company combines local retail expertise with global best practices in audiology, consumer engagement and after-sales support. Its international platform enables consistent service delivery and innovation in hearing solutions tailored to diverse regulatory environments and patient needs.AI Generated. May Contain Errors. Read More Receive AMFPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplifon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMFPF Stock News HeadlinesEssilorLuxottica considered investing in Amplifon in the past, CEO saysApril 28, 2026 | reuters.comAmplifon S.p.A. (AMFPF)April 2, 2026 | sg.finance.yahoo.comSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page. | Weiss Ratings (Ad)AMFPF Amplifon S.p.A.March 5, 2026 | seekingalpha.comAmplifon SpA (AMFPF) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...March 4, 2026 | finance.yahoo.comAmplifon S.p.A. (AMFPF) Q4 2025 Earnings Call TranscriptMarch 4, 2026 | seekingalpha.comBNY Mellon International Equity Fund Q3 2025 CommentaryNovember 22, 2025 | seekingalpha.comAmplifon S.p.A. (AMFPF) Price Target Decreased by 34.71% to 21.02November 18, 2025 | msn.comSee More Headlines AMFPF Stock Analysis - Frequently Asked Questions How have AMFPF shares performed this year? Amplifon's stock was trading at $15.5550 at the start of the year. Since then, AMFPF stock has decreased by 27.9% and is now trading at $11.21. How were Amplifon's earnings last quarter? Amplifon S.p.A. (OTCMKTS:AMFPF) issued its quarterly earnings data on Monday, June, 1st. The company reported $999.00 earnings per share (EPS) for the quarter. Amplifon had a net margin of 2.87% and a trailing twelve-month return on equity of 16.04%. How do I buy shares of Amplifon? Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings6/01/2026Today6/26/2026Next Earnings (Estimated)7/30/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Services Sub-IndustryN/A Current SymbolOTCMKTS:AMFPF CIKN/A Webcorporate.amplifon.com Phone(390) 257-4721FaxN/AEmployees15,078Year Founded1950Profitability EPS (Trailing Twelve Months)$0.36 Trailing P/E Ratio31.14 Forward P/E Ratio2.95 P/E GrowthN/ANet Income$103.33 million Net Margins2.87% Pretax Margin5.50% Return on Equity16.04% Return on Assets4.20% Debt Debt-to-Equity Ratio0.57 Current Ratio0.48 Quick Ratio0.42 Sales & Book Value Annual Sales$2.71 billion Price / Sales0.91 Cash Flow$2.44 per share Price / Cash Flow4.60 Book Value$5.14 per share Price / Book2.18Miscellaneous Outstanding Shares219,940,000Free FloatN/AMarket Cap$2.47 billion OptionableNot Optionable Beta0.68 Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (OTCMKTS:AMFPF) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplifon S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplifon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
